comparemela.com

Latest Breaking News On - Dynavax technologies daily - Page 3 : comparemela.com

Federated Hermes Inc Trims Stake in Dynavax Technologies Co (NASDAQ:DVAX)

Federated Hermes Inc. reduced its position in Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) by 10.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 11,364,666 shares of the biopharmaceutical company’s stock after selling 1,264,059 shares during the quarter. Federated Hermes Inc. owned 0.09% […]

Executive Wealth Management LLC Invests $280,000 in Dynavax Technologies Co (NASDAQ:DVAX)

Executive Wealth Management LLC acquired a new position in Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 20,000 shares of the biopharmaceutical company’s stock, valued at approximately $280,000. Several other hedge funds have also recently […]

Short Interest in Dynavax Technologies Co (NASDAQ:DVAX) Expands By 6 0%

Dynavax Technologies Co. (NASDAQ:DVAX – Get Free Report) was the target of a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 17,350,000 shares, an increase of 6.0% from the February 29th total of 16,370,000 shares. Based on an average daily trading volume, of 1,960,000 […]

Dynavax Technologies Co (NASDAQ:DVAX) Position Lowered by jvl associates llc

jvl associates llc decreased its stake in shares of Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) by 19.7% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 29,142 shares of the biopharmaceutical company’s stock after selling 7,149 shares during the period. jvl associates llc’s holdings in […]

Seven Eight Capital LP Buys Shares of 40,029 Dynavax Technologies Co (NASDAQ:DVAX)

Seven Eight Capital LP purchased a new stake in shares of Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 40,029 shares of the biopharmaceutical company’s stock, valued at approximately $591,000. Other […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.